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Abstract
Background: The uterus is a histologically dynamic organ, and the mechanisms coordinating its regeneration
during the oestrous cycle and implantation are poorly understood.
The aim of this study was to isolate, immortalize and characterize bovine endometrial mesenchymal stem cell
(eMSC) lines from different oestrous cycle stages (embryo in the oviduct, embryo in the uterus or absence of
embryo) and examine their migratory and immunomodulatory properties in an inflammatory or implantation-
like environment, as well as possible changes in cell transdifferentiation.
Methods: eMSCs were isolated and analysed in terms of morphological features, expression of cell surface and intracellular
markers of pluripotency, inmunocytochemical analyses, alkaline phosphatase activity, proliferation and osteogenic
or chondrogenic differentiation capacities, as well as their ability to migrate in response to inflammatory (TNF-α
or IL-1β) or implantation (IFN-τ) cytokines and their immunomodulatory effect in the proliferation of T cells.
Results: All eMSCs showed MSC properties such as adherence to plastic, high proliferative capacity, expression of
CD44 and vimentin, undetectable expression of CD34 or MHCII, positivity for Pou5F1 and alkaline phosphatase activity.
In the absence of an embryo, eMSC showed an apparent mesenchymal to epithelial transition state. eMSC during the
entire oestrous cycle differentiated to osteogenic or chondrogenic lineages, showed the ability to suppress T
cell proliferation and showed migratory capacity towards pro-inflammatory signal, while responded with a block in their
migration to the embryo-derived pregnancy signal.
Conclusion: This study describes for the first time the isolation, immortalization and characterization of bovine
mesenchymal stem cell lines from different oestrous cycle stages, with a clear mesenchymal pattern and
immunomodulatory properties. Our study also reports that the migratory capacity of the eMSC was increased towards
an inflammatory niche but was reduced in response to the expression of implantation cytokine by the embryo.
The combination of both signals (pro-inflammatory and implantation) would ensure the retention of eMSC in
case of pregnancy, to ensure the immunomodulation necessary in the mother for embryo survival. In addition, in
the absence of an embryo, eMSC showed an apparent mesenchymal to epithelial transition state.
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Background
In ruminants, embryo mortality is a key factor affecting fer-
tility [1]. Approximately 50% of pregnancy loss occurs be-
tween blastocyst hatching and embryo attachment to
endometrium in cattle [2]. Efficient communication be-
tween cells and tissues is paramount in many physiological
processes, including embryo development. Preimplanta-
tional embryos of mammals develop within the female
genital tract (oviduct and uterus) and their efficient com-
munication conditions their development and survival. In
ruminants, the bicornuate uterus is coated with the endo-
metrium, the ultimate and unique biological layer facing
the implanting embryo in normal early pregnancy, which
drives the development of the embryonic disc and
extra-embryonic tissues [3]. The endometrium displays two
specific areas, namely the caruncles and the intercaruncular
areas. The caruncles represent aglandular structures of lim-
ited size that are distributed over the endometrial surface.
The intercaruncular areas are large and contain the endo-
metrial glands, which produce histotroph, a collection of
numerous and diverse factors including cytokines and
growth factors [4].
During the window of implantation, after blastocyst at-
tach onto the endometrium, both in human and mice,
characterized by haemochorial implantation, the stromal
cells at the implantation site begin to undergo deciduali-
zation, a process by which the fibroblast-like endomet-
rial stromal cells differentiate into polygonal epithelial-
like cells [5]. The differentiation of decidual cells is one
of the earliest uterine adaptations to pregnancy in these
species [6] and involves cell growth, change of shape,
multinucleation and establishment of inter-cellular junc-
tions [7]. Many genes and signal pathways are involved
in the process of decidualization that is crucial for
blastocyst implantation and maintenance of pregnancy.
Ruminants and pigs have noninvasive implantation;
however, they differ in the type of placentation. Pig con-
ceptuses undergo epitheliochorial placentation in which
luminal epithelium (LE) remains morphologically intact
throughout pregnancy and the conceptus trophectoderm
simply attaches to the apical LE surface without contact-
ing uterine stromal cells [8]. In contrast, synepithelio-
chorial placentation in ruminants involves extensive
erosion of the LE due to syncytium formation with
trophectoderm binucleate cells. After day 19 of preg-
nancy, the conceptus tissue is apposed to, but does not
penetrate, uterine stroma.
Johnson el al. reported that the uterine stroma of sheep
undergoes a programme of differentiation similar to
decidualization in invasive implanting species, whereas
porcine stroma exhibits differentiation that is more lim-
ited than that in sheep, rodents or primates [9].
The uterus is a histologically dynamic organ, and the
mechanisms coordinating its regeneration during the
oestrous cycle and implantation are poorly understood.
It has been proposed that bone marrow-derived cells
contribute to uterine regeneration [10]. An alternative or
additive mechanism of endometrial regeneration could
be in situ cellular transdifferentiation, an example of
which is mesenchymal to epithelial transition (MET).
During MET, mesenchymal cells are re-programmed,
thereby gradually losing mesenchymal cell characteristics
while gaining epithelial cell traits [11]. MET and epithe-
lial to mesenchymal transition (EMT) are fundamental
processes that occur during the bovine embryo develop-
ment and are also implicated in tumour metastasis [12].
Uchida et al. reported that the EMT might play an im-
portant role in human embryo implantation helping the
embryo to penetrate through the endometrial epithelial
cells into the endometrial stromal cell layer [13]. In
addition, Zhang et al. suggested that MET might exist
during decidualization, providing a stable developmental
environment and an anchor point for embryos to invade
into the uterus [14]. Recently, Patterson et al. reported
that MET contributes to endometrial regeneration fol-
lowing natural and artificial decidualization by sesame
oil injection into the uterine lumen in mouse [15], but
the possibility that this cellular transdifferentiation also
serves as a mechanism to regenerate adult endometrium
in bovine has not been evaluated.
Although the presence of stem cells in the endomet-
rium was first speculated in 1978 by Prianishnikov [16],
it was not until 2004 that stem cells were identified and
characterized for the first time in the endometrial tissue
[17, 18]. The adult stem cells, mesenchymal stem cells
(MSCs), unlike pluripotent embryonic stem cells, are
multipotent and can produce a limited range of cell line-
ages depending on their location. MSCs are isolated
from virtually every tissue, so that their stem cell proper-
ties are difficult to predict in an in vivo setting. The
presence in the bovine endometrium of mesenchymal
stem cells (eMSCs) has been already described [19–21].
Bovine eMSCs possess several MSC properties such as
clonogenicity, ability to adhere to plastic, fibroblast
morphology and in vitro differentiation capacity to adi-
pocyte, chondrocyte and osteocyte [22]. Moreover, bo-
vine eMSCs present high levels of CD29, CD44 and
vimentin markers, low expression levels for CD34 and
no MHC-II [21]. It is important to highlight that in
some cases MSCs are able to divide but to a limited
extent in vitro before entering replicative senescence. Be-
tween passages 7 and 12, MSCs increase their cell size and
reduce the expression of certain pluripotency markers,
leading to proliferative arrest [23].
MSCs have the ability to migrate to damaged and in-
flamed tissues where they proliferate and utilize their
immunomodulatory properties as part of the regener-
ation process of the tissue itself [24–26]. The immune
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reaction has classically been functionally divided into
Th-1 and Th-2 responses. Although, in human, numer-
ous studies attempted to support pregnancy as a Th-2 or
anti-inflammatory state [27], a similar number of studies
supported its condition as a Th-1 or pro-inflammatory
state [28]. A two-phase model was thereafter proposed
by Mor et al., being the first and third trimesters charac-
terized by a pro-inflammatory ambient, while the second
trimester would represent an anti-inflammatory phase
[29]. MSC can suppress or reduce the proliferation of T
cells and also have a role in the regulation of Th-1/Th-2
balance shifting a Th-1 phenotype to a Th-2 [30]. MSC
interactions with immune cells have been studied widely
in both humans and rodents even in pigs [24], although
this research has not yet been extended to MSC from
the main veterinary species.
In ruminants, the major embryo-derived signal of
pregnancy recognition has been suggested to be type I
interferon [31]. The production of this interferon (inter-
feron-tau; IFN-τ) is unique as it is secreted by trophecto-
derm cells during the elongation phase and secretion
stops when trophectoderm cells appose to the endomet-
rial luminal epithelium. IFN-τ is crucial for maternal
recognition through the inhibition of endometrial
prostaglandin-F2 alpha secretion, thus preventing luteo-
lysis, an indispensable step for maintaining P4 luteal se-
cretion [32].
Taking all this information into account, we have ad-
dressed the isolation, immortalization and characterization
of eMSC from different phases of the bovine oestrous cycle
in terms of their ability to migrate in vitro by agarose spot
assay mediated by inflammatory cytokines (TNF-α or
IL-1β) or the implantation cytokine (IFN-τ). We have also
evaluated their possible immunomodulating function in a
xenogeneic condition.
Methods
Isolation and culture of bovine endometrial mesenchymal
stem cells (eMSCs)
Heifer uterus and ovaries were collected from routine
slaughtered at the local abattoir. Oestrous cycle stages
were determined by a macroscopic examination of the
luteum corpus and ovarian morphology of the cycling
heifers according to literature criteria [33] (see Table 1).
The uterine horns ipsilateral to the luteum corpus were
removed and washed with fresh tap water, and the uter-
ine lumen was washed three times using a 20-ml syringe
with Hank’s balanced salt solution (HBSS) supplemented
with 500 U/ml penicillin, 500 mg/ml streptomycin and
0.1% bovine serum albumin (BSA) (Merck KGaA, Darm-
stadt, Germany) by flushing from the utero-tubal junc-
tion. To obtain bovine endometrial cells, a longitudinally
cut of the uterine horn was performed with sterile scis-
sors. The intercaruncular endometrium was carefully
dissected from underlying tissues, cut in strips, minced
using sterile scissors and incubated in 25-ml type II col-
lagenase solution: HBSS supplemented 0.05% type II col-
lagenase (Gibco by Life Technologies, Grand Island, NY,
USA), 0.1% BSA (Merck KGaA, Darmstadt, Germany)
and 30mM CaCl2. The solution was homogenized and
incubated during 1 h at 37 °C shaking gently every 10
min. The solution resulting from the digestion was fil-
tered through a 70-μm cell strainer (SPL life science,
Korea), and a volume of culture medium RPMI (Hyclone
Laboratories, Utah, USA), supplemented with 10% foetal
calf serum (PAA laboratories, Austria), 2% non-essential
amino acids and antibiotics (100 U/ml penicillin, 100
mg/ml streptomycin), was added to block the action of
collagenase and the obtained suspension centrifuged at
300 × g for 5 min. The resulting pellets were resuspended
in culture medium and plated in 100-mm2 tissue culture
dish (JetBiofil, Guangzhou, China) and incubated in an
atmosphere of humidified air and 5% CO2 at 37 °C. Cul-
ture medium was changed every 48–72 h.
eMSC immortalization
PA-317 LXSN-16E6E7 cells were acquired from the
American Type Culture Collection (Manassas, VA).
Virus was harvested from 16-h conditioned media of
PA-317 cells that and filtered through a 0.45-mm low
protein binding filter (Millipore, Bedford, MA) to re-
move cells and debris. Ten microlitres of viral super-
natant was obtained from a confluent P100 dish. Viral
supernatant was diluted 1:3 with serum-free DMEM/
RPMI medium containing polybrene (4 mg/ml; Sigma).
Primary cultures of bovine endometrial cells obtained
from different cyclic stages which have been grown to
60% confluence in P100 culture dishes were overlaid
Table 1 eMSC isolation and immortalization efficiency
Oestrous cycle stage Embryo location Primary
cultures
Immortalization
efficiency
Immortalized
eMSC
Oestrous
stage
D2-D4 early luteal Embryo in the oviduct 4 1 (25%) 1A 1
D4-D8 medium luteal Embryo in the uterus with zona pellucid (ZP) 4 0 (0%) – 2
D9-D16 late luteal Embryo in the uterus w/o ZP 8 3 (37.5%) 3A, 3D, 3E 3
D17-D21 follicular phase Regression of corpus luteum if not embryo 6 4 (66.7%) 4B, 4C, 4D, 4H 4
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with 3ml of this mixture and incubated in an atmos-
phere of humidified air and 5% CO2 at 37 °C for 3 h.
After 3–4 h, viral supernatant was removed; cells were
washed twice with HBSS, and complete culture medium
was added to dishes. After 48 h, cells having integrated
the vector were selected by resistance to the neomycin
analogue G418 300 μg/ml (Gibco of Life Technologies,
Grand Island, NY, USA) in complete culture medium.
Selection continued for 7 days, and surviving cells were
subsequently cultured with complete culture medium
containing 100 μg/ml G418 for general cell maintenance.
The G418-resistant cell populations were subcultured
for more than 30 passages, and immortalized cells were
cryopreserved each passage.
eMSC characterization by flow cytometry
Surface, cytoplasmic and nuclear cell antigens were ana-
lysed by flow cytometry using a Cell Lab Quanta SC sys-
tem of Beckman Coulter. Cell cultures at 80–90%
confluence were detached using 0.05% trypsin–EDTA
(T/E) solution, collected and fixed with 4% paraformal-
dehyde for 10 min and subsequently washed twice with
PBS. For the analysis of the expression of vimentin
(clone LN-6, Sigma-Aldrich) and cytokeratin (Clone
C-11, Sigma-Aldrich) (cytoplasmic proteins) and
POU5F1 (rabbit polyclonal, Biorbit) (a nuclear protein),
cell permeabilization was performed by incubation with
0.3–0.5% Triton X-100 for 10 min and washing with
PBS. Nonspecific binding of antibodies was blocked with
TNB-blocking solution during 30 min at 37 °C. Appro-
priated dilutions, provided by manufacturers, of primary
antibodies against the markers commonly used to define
mesenchymal stromal cells (MSCs): vimentin (clone
LN-6, Sigma-Aldrich) and CD44 (clone IM7, Bio-rad), as
positive markers; cytokeratin, CD34 (Rabbit polyclonal,
Biorbyt), and MHCII (clone CVS20, Bio-Rad) as negative
markers; and POU5F1 as pluripotency marker, were
added to the cells and incubated overnight at 4 °C. Cells
were then stained with the appropriated Alexa Fluor
488-conjugated secondary antibodies (Jackson InmunoR-
esearch Laboratories, Baltimore Pike, West Grove, PA).
Negative control samples were produced by the omis-
sion of the primary antibody. Analysis of the samples
was performed with Cell Lab Quanta SC system of Beck-
man Coulter using Flow-Jo X SOFTWARE version
10.0.7r2.
Alkaline phosphatase (AP) activity
eMSC lines at passages 10–15 were grown on 35-mm
dishes (JetBiofil, Guangzhou, China) for 2 weeks. Cells
were washed twice with PBS and fixed with a solution of
4% paraformaldehyde during 10min at room temperature.
Paraformaldehyde was aspirated, and the plates were
washed twice with distilled water and covered with B
solution (1ml of Solution A (Fast Red 1mg/ml), 1.6 μl of
Napthol AS-mx phosphate and 40 μl TRIS HCl 1M, pH
8.6) during 10–15min at room temperature in the dark.
Solution B was finally removed, and the cells were washed
twice with PBS and covered with PBS to prevent drying.
The colonies were studied for appearance of pink/red col-
oration indicating alkaline phosphatase activity. The
stained colonies were imaged using a Motic SMZ-171
stereomicroscope coupled to a Moticam BTU8 digital
camera using Motic Image Plus software version 2.0
(Motic China Group Co., LTD).
Cell proliferation measurement
Different mesenchymal cell lines of passages 10–15 were
seeded at 2 × 105 cells per 60-mm tissue culture plates
(JetBiofil, Guangzhou, China). The culture medium was
changed every 2 days. At each time point, a duplicate of
plates was detached by tripsinization and counted using
a Bürker counting chamber (Paul Marienfeld GmbH &
Co. Lauda-Königshofen, Germany). Twenty microlitres
of cell suspension was placed on both sides of the cham-
ber and viewed using × 100 magnification under an
inverted Nikon Diaphot phase contrast microscope
coupled to a Jenoptik ProgRes CT1 digital camera. Im-
ages were taken using ProgRes capture pro software ver-
sion 2.7 (Jenoptik Laser, Optic Systeme GmbH). A total
of 5 × 1mm2 squares per sample were analysed, and the
number of cells per millilitre was determined according
to number of cells in 1 ml =N/Z × dilution × 104, where
N = the whole number of cells counted and Z = the num-
ber of counted squares. Cell population doubling time
(PDT) was calculated using Roth V. 2006 Doubling Time
Computing, available from http://www.doubling-time.
com/compute.php.
In vitro differentiation potential assay
eMSC lines at passages 10–15 were grown until 90%
confluence on 24-well multidish (JetBiofil, Guangzhou,
China). For osteogenic differentiation, The StemPro®
Osteogenesis Differentiation Kit (Thermo Fisher Scien-
tific, Meridian Road Rockford, IL, USA) was used accord-
ing to the manufacturer’s instructions. Differentiating
media was changed every 3–4 days for 21 days. Simultan-
eously, control cells were cultured in standard conditions.
Cells were then fixed in 4% paraformaldehyde solution for
30min. After fixation, cells were incubated for 2–3min in
2% Alizarin Red S solution (pH 4.2) to visualize the cal-
cium deposits.
For chondrogenic differentiation, The StemPro® Chon-
drogenesis Differentiation Kit (Thermo Fisher Scientific,
Meridian Road Rockford, IL, USA) was used according
to the manufacturer’s instructions. Differentiating media
was changed every 2–3 days for 14 days. Simultaneously,
control cells were cultured in standard conditions. Cells
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were then fixed in 4% paraformaldehyde solution for 30
min. After fixation, cells were incubated for 30 min with
1% Alcian Blue solution prepared in 0.1 N HCl. Blue stain-
ing was corresponding with proteoglycans synthetized by
chondrocytes. Cells under differentiation conditions were
photographed, using a Motic SMZ-171 stereomicroscope
coupled to a Moticam BTU8 digital camera.
Cell migration measurement: agarose spot assay
The cell migration measurement by agarose spot assay
was carried out following the procedures of Calle et al.
[34]. Briefly, PBS-0.5% agarose solution was heated on a
water bath until boiling to facilitate complete dissol-
ution. When the temperature cooled down to 40 °C,
90 μL of agarose solution was pipetted into a 1.5-ml
Eppendorf tube containing 10 μL of PBS or PBS supple-
mented with TNF-α, IL-1β or IFN-τ for a final concen-
tration of 6 nM [33]. Five-microlitre spots of agarose-
containing PBS, TNF-α or IL-1β were pipetted onto
six-well plates (JetBiofil, Guangzhou, China), 16 drops
per well, 12 drops per MSC line, and allowed to cool for
15 min at 4 °C. At this point, cells that had been treated
with 1 μg/ml C-Mitomycin overnight (Merck KGaA,
Darmstadt, Germany) to avoid cellular duplication were
plated onto spot-containing dishes in the presence of
culture media and onto two dishes for mitomycin con-
trol, using Bürker counting chamber. Imaging was per-
formed at 24 and 48 h using a Motic SMZ-171
stereomicroscope coupled to a Moticam BTU8 digital
camera using Motic Image Plus software version 2.0
(Motic China Group Co., LTD). Motile cells penetrated
the agarose spot. The longest straight distance from the
border of the spot was analysed for each cell using ImageJ.
In vitro xenostimulatory assays
To measure immunomodulatory properties of eMSCs, a
co-culture of eMSCs and human T cells was performed.
Human peripheral blood mononucleated cells (PBMCs)
from peripheral blood of healthy donors were obtained
by Ficoll Hypaque Plus (GE Healthcare) density centrifu-
gation. T cells were then isolated from PBMCs using the
Easy Sep Human T cell Enrichment Kit (Stem Cell Tech-
nologies) following the manufacturer’s instructions.
Briefly, cells were diluted in a column buffer at a con-
centration of 5·107 cells/ml, labelled with the tetrameric
antibody complexes (TAC) recognizing human CD14,
CD16, CD19, CD20, CD36, CD56, CD66b, CD123, gly-
cophorin A and dextran-coated magnetic particles and
separated using the EasySep magnet (StemCell Tech-
nologies). Enriched T cells were then washed and resus-
pended in PBS with an equal volume of CellTrace™
Violet (Thermo Fisher Scientific) for 10 min. After an
overnight resting period, labelled T cells were washed
twice with RPMI supplemented with 10% FBS and plated
at 3·105 cells/well in flat-bottomed well plates in which
eMSC-1A or eMSC-4H had been previously seeded
(50.000 cells/well) with RPMI medium. T cells had a via-
bility of over 94% in all experiments performed and were
stimulated with anti-CD2/CD3/CD28-coated microbeads
(Pan T Cell Activation Kit; Miltenyi Biotech) or un-
coated microbeads as a negative control in a 1:10 bead
to T cell ratio. Xenoproliferation was determined after
4.5 days by measuring the CellTrace™ Violet loss by flow
cytometry in a LSR Fortessa Analyzer (BD Biosciences).
Statistical analysis
Statistical analysis was performed using GraphPad Prism 6
(GraphPad Software, La Jolla, CA, USA). One-way ANOVA
for multiple comparisons by Fisher’s LSD tests were used
for cell proliferation and doubling time. Two-way ANOVA
for multiple comparisons by Fisher’s LSD tests were used
for cell migration. Values are presented in mean ± standard
error of the mean (SEM). Differences were regarded as sig-
nificant when p < 0.05. Two-tailed Student’s t tests were
used when two groups were compared for immunomodula-
tory assays. Values are expressed as mean ± standard error
of the mean (SEM). Differences were considered to be sig-
nificant when p < 0.05.
Results
MSC isolation and immortalization efficiency
eMSCs were isolated from heifer uterus that were as-
cribed to one of the four bovine oestrus stage categories
(1–4) (Table 1) proposed by [33] based on the morph-
ology of the active ipsilateral ovary to the uterine horn
from which the cells were isolated. To avoid the risk of
senescence by the maintenance of eMSC in vitro, iso-
lated cells were immortalized using the retroviral vector
LXSN-16E6E7. From a total of 22 primary cultures of
endometrial stromal cells, eight cell lines were success-
fully immortalized (eMSC-1A, eMSC-3A, eMSC-3D,
eMSC-3E, eMSC-4B, eMSC-4C, eMSC-4D, eMSC-4H)
(Table 1).
Morphological features
Pre-immortalized mesenchymal stem cell cultures at
passage 0 adhered to the plastic surface of culture dishes
exhibiting a mixture of round, spindle or elongated
shape morphology (Fig. 1—upper panels). However, after
the first cell passage, the cells formed a more homoge-
neous population of fibroblast-like adherent cells, with
the exception of eMSC-4D and eMSC-4H that showed
an epithelial-like morphology remained constant before
and after the immortalization even after more than 20
passages (Fig. 1—lower panels).
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Expression of cell surface, intracellular and pluripotent-
specific markers
Some characteristic MSC surface and intracellular
markers were assessed by flow cytometry (Fig. 2a–c). All
cell lines were positive for cell surface CD44 and cytoplas-
mic vimentin, both of them are characteristic markers of
MSCs. Interestingly, cytokeratin, a typical cytoplasmic
marker expressed by epithelium of ectoderm and endo-
derm, and commonly used as a negative marker of mesen-
chymal stem cells, was present in all stage 4 eMSC lines:
strongly detected in eMSC-4H, clearly positive in
eMSC-4C and slightly positive in eMSC-4B and eMSC-4D
(Fig. 2b), correlating with the epithelial morphology of
two of these cell lines. No expression of haematopoietic
markers, such as MHCII or CD34, was found in any of
the eMSC lines. Regarding pluripotency features, all eMSC
lines, including those cell lines immortalized from the
follicular phase and with epithelial morphology, were posi-
tive for the nuclear marker POU5F1 (Fig. 2c) and showed
alkaline phosphatase activity (Fig. 2d).
Proliferation capacity
To analyse the cell proliferation capacity of eMSCs, the
number of cells/dish was counted for each cell line at
days 3, 5, 7 and 10, starting in all cases from an initial
seeding of 2 × 105 cells. As showed in Fig. 3a, the num-
ber of cells increased for all cell lines along the entire
assay, demonstrating high proliferative capacity of these
cells even at passages 10–15. eMSC-4H was the most
proliferative line and at day 10 reached 19.74 × 105 ±
2.13 × 105 cells. Figure 3b shows the proliferation rate
of MSC lines in terms of the population doubling time
(PDT). Among eMSC lines, eMSC-4H and eMSC-4D
Fig. 1 Morphology of MSCs. Pre-immortalized mesenchymal stem cell cultures at passage 0 (upper panels) and immortalized mesenchymal stem
cell lines at passages 10–15 (lower panels). Phase-contrast images were acquired with × 100 magnification
Fig. 2 Expression of cell surface, intracellular and pluripotent specific markers and alkaline phosphatase activity. a–c Analysis by flow cytometry of
the expression levels of cell surface markers CD34, CD44 and MHCII and intracellular markers cytokeratin, vimentin and POU5F1 in eMSC.
Data correspond to the mean fluorescence intensity (folds of negative control) for each sample. d Analysis of AP activity: bright field images were obtained
at × 50 magnifications, showing some red-stained cell groups after the action of alkaline phosphatase on Fast Red in the presence of Napthol
AS-mx phosphate. Bars = 150 μm
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showed on day 10 a significantly shorter PDT of 5.77 ±
0.47 and 3.50 ± 0.23 days, respectively (p < 0.05).
In vitro differentiation of MSCs
As showed in Fig. 4, all eMSC lines cultured under
osteogenic conditions presented a comparable amount
of calcium deposits, indicating a high osteogenic differ-
entiation potential of these lines. Cells cultured under
chondrogenic conditions showed the presence of acidic
proteoglycan that was demonstrated at monolayer cells
by Alcian blue staining, presenting in most cases stained
nodules typical from cartilaginous tissue.
All this characterization demonstrates that all immor-
talized lines complied with MSC features in terms of
marker expression and differentiation capacities, even
those obtained from the follicular phase that showed
cytokeratin expression and epithelial morphology.
Migratory response of MSC to inflammatory and
implantational stimuli
Assessment of the invasive capacity of all eMSC lines
was performed using the agarose spot assay [34], which
allows the quantification of cell invasion by measuring
their crawling underneath an agarose gel on a planar
surface. All eMSC lines showed migration capacity into
agarose spots without cytokine stimuli from day 2
(Fig. 5). In terms of migration without cytokine stimuli,
eMSC-4C showed a significantly higher migration rate
than the rest of eMSC lines with a net migrated distance
of 1008.0 ± 38.26 μm on day 7 (Fig. 5B).
The inflammatory cytokine TNF-α did not cause an
increase in the migration capacity of any of the eMSC
lines studied compared to the control of PBS, but com-
pletely abrogated that of eMSC-3D and eMSC-4B. In
contrast, the inflammatory cytokine IL-1β stimulated the
A B
Fig. 3 In vitro proliferation of mesenchymal stem cells. a Absolute number of cells/dish (mean ± SD) at indicated points. b Doubling time in days
of each MSC line (mean ± SD). Different letters indicate significant differences (p < 0.05)
Fig. 4 In vitro differentiation of eMSC to different lineages. Images show Alizarin Red S staining of calcium deposits in cells cultured in basal
medium (control) or in osteogenic differentiation medium (top panel); Alcian blue staining of acidic proteoglycan in cells cultured in basal
medium (control) or in chondrogenic differentiation medium (bottom panel). Bright field images were acquired with a × 3 magnification (bars = 150 μm)
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migration capacity of cell lines eMSC-1A, eMSC-3A,
eMSC-3E, eMSC-4C and eMSC-4H while caused a re-
duction in the cell migration rate of only the eMSC-
4B line.
Regarding the preimplantation protein IFN-τ, it re-
duced cell motility of most cell lines (Fig. 5C).
Immunomodulatory properties
Although all eMSC immortalized lines showed MSC dif-
ferentiation capacities, those obtained from the follicular
phase had unexpected features such as cytokeratin ex-
pression and epithelial morphology. Thus, we analysed
the immunomodulatory potential of two representative
lines: eMSC-1A with a pure mesenchymal pattern and
eMSC-4H with a phenotype consistent with MET. Co-
culture experiments with human T cells activated with
anti-CD2/3/28 beads were established to analyse eMSC’s
influence on polyclonal xenogeneic proliferation. The
percentage of proliferating cells was determined by flow
cytometry, quantifying FSChighVioletlow T cell blasts
(Fig. 6a, b). An almost complete abrogation of activated
human T cell proliferation was observed when these
cells were co-cultured with either eMSC-1A (p < 0.0001)
or eMSC-4H (p < 0.0001) (Fig. 6c).
Discussion
We have successfully isolated, immortalized and charac-
terized eMSC from different phases of the bovine
oestrous cycle. The results of the present study clearly
demonstrated that immortalized eMSC showed MSC
properties such as adherence to plastic, high proliferative
capacity until passages 10–15 and surface expression of
CD44 and intracellular expression of vimentin, both
MSC markers. Moreover, all eMSC lines were negative
Fig. 5 Migration analysis in an agarose spot assay. A Representative images of eMSC-4C migration assay into a PBS-, TNF-α-, IL-1β- or IFN-τ-containing
agarose spot at the indicated times. Images were obtained in a light stereomicroscope at × 20 magnification. b and c Migratory response
of MSC to inflammatory and implantational stimuli. b The distance migrated from the border of the PBS-agarose spot was measured in
two independent experiments for all eMSC lines at the indicated times (mean ± SD). Different letters indicate significant differences: p < 0.005 for
eMSC migration mediated by PBS at day 7 (a, b, c, d, e); C p < 0.05 for eMSC migration mediated by PBS (a, b, c), p < 0.005 for eMSC migration
mediated by TNF-α (e, f, g) and p < 0.05 for eMSC migration mediated by IL-1β (i, j, k, l) and IFN-τ (p, q). *p < 0.05; ***p < 0.0005; ****p < 0.0001
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for haematopoietic specific markers CD34 and MHCII
and positive for pluripotency-related marker Pou5F1, a
nuclear protein that is well known for pluripotency
maintenance and is expressed in bovine MSCs [20]. Nu-
merous studies demonstrate that the ability to express
alkaline phosphatase activity is also a pluripotency
marker of stem cells [35]. In this report, immortalized
eMSC lines from different phases of the bovine oestrous
cycle showed positivity in AP activity.
All eMSC lines from early and late luteal phases
showed a fibroblast-like morphology characteristic of
MSC and expressed vimentin. Interestingly, eMSC lines
obtained from the follicular phase (absence of an em-
bryo) expressed cytokeratin and two of these lines
showed a clear epithelial-like morphology. This observa-
tion could reflect a mesenchymal to epithelial transition
(MET) of eMSC, a process in which mesenchymal cells
are re-programmed, thereby gradually losing mesenchy-
mal cell characteristics while gaining epithelial cell traits
[11]. In both mouse and human, uterine regeneration
was shown to occur both by bone marrow-derived cells
[10] and also by MET of resident cells [14, 15]. Cousins
et al. demonstrated that MET contributes to endometrial
epithelium after progesterone withdrawal-induced tissue
breakdown in a mouse model of menstruation [36]. This
finding is consistent with Yu et al. observations showing
that luteal hormone concentration and/or duration
thresholds confer plasticity and reversibility of endomet-
rial stromal phenotype via MET [37]. In bovine, proges-
terone produced by the corpus luteum is essential for
the establishment and maintenance of pregnancy. Rapid
regression of the cow’s corpus luteum is a key event in
the bovine oestrous cycle as it is responsible for the pre-
cipitous decrease in the blood concentration of proges-
terone, the end of the cycle (follicular phase) [38]. Our
eMSC lines established from the different phases of the
oestrous cycle show a clear mesenchymal pattern in the
early luteal phase (eMSC-1A, corresponding to the
A C
B
Fig. 6 Measurement of T cell proliferation suppression capacity by eMSC. a, b Representative plots of non-stimulated and stimulated (anti-CD2/
CD3/CD28-coated microbeads) human T cell control conditions (in the absence of MSCs). c Percentage of proliferating stimulated T cells in the
presence of eMSC-1A or eMSC-4H (X:X T:eMSC ratio ± 0.54 and ± 0.63 respectively); proliferative T cell were analysed by Violet CellTrace
fluorescence loss after a 4.5-day culture. Results are reported as percentage of proliferating T cells relative to the proliferation of activated
T cells in the absence of eMSCs (positive control). ****p < 0.0001
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presence of the embryo in the oviduct) and late luteal
phase (eMSC-3A, eMSC-3D and eMSC-3E, correspond-
ing to the presence of the embryo in the uterus), while
an apparent mesenchymal to epithelial transition state is
observed in eMSC from the follicular phase (eMSC-4B,
eMSC-4C and eMSC-4D, and eMSC-4H corresponding
to the regression of the corpus luteum if there was no
embryo) since they express cytokeratin and in some
cases show an epithelial morphology. Considering that
both the epithelium and the bovine stroma present
oestrogen and progesterone receptors during the
oestrous cycle [39], it would be interesting to analyse in
future experiments the paracrine function performed by
the eMSCs, thanks to the possible expression of hor-
mone receptors during the oestrous cycle.
The ability to differentiate in vitro to mesodermal
lineages has been demonstrated for eMSC isolated
from the endometrium at the medium luteal phase
[20] or medium and late luteal phase [21], but it was
not known if the MSCs present in the uterus con-
served such multipotency capacity during the entire
oestrous cycle. Our data on osteogenic and chondro-
genic induction with eMSC lines confirmed their mul-
tipotency, both in the early and late luteal phases as
well as in the follicular phase.
An important characteristic of MSCs is their ability to
migrate to damaged tissues or to inflammatory processes.
All eMSC lines showed migration capacity without cyto-
kine stimulation. There was not a clear difference in terms
of non-stimulated migration between eMSC lines from dif-
ferent oestrus phases or with different morphologies
(mesenchymal or epithelial). Although the eMSC lines ob-
tained from the follicular phase (absence of an embryo)
expressed cytokeratin and two of these lines showed clear
epithelial type morphology, they also showed a high migra-
tion capacity and showed intracellular expression of
vimentin. Vimentin is an important marker of mesenchy-
mal to epithelial transition and a requisite regulator of
mesenchymal cell migration. During MET, vimentin pro-
tein and mRNA expression are downregulated as cell mo-
tility decreases and cells adopt epithelial characteristics
[40, 41]. Taking into account the above, MSCs show a cel-
lular plasticity characteristic of MET that allows them to
show characteristics of mesenchymal and epithelial cells.
In all scenarios, either when the embryo is still in the ovi-
duct (phase 1), or when the embryo without zona pellucida
is in the uterus (phase 3), or in case of regression of the
corpus luteum as a consequence of the absence of an em-
bryo in the uterus (phase 4), most of the eMSCs present
an active migration towards a pro-inflammatory niche
(Th-1) characterized by the presence of IL-1β and de-
scribed in the initial and final stages of human gesta-
tion [29]. In contrast, most of the eMSCs from the
three scenarios described respond with a block in their
migration to IFN-τ, the major embryo-derived preg-
nancy signal in bovine [31]. This is in clear contrast
with the effect of this cytokine on bovine MSC derived
from bone marrow, which are attracted by IFN-τ
(Calle et al., under revision). The combination of both
IL-1 and IFN-τ signals would ensure the retention of
eMSC in case of pregnancy, as well as further recruit-
ment of MSC from the bloodstream, to ensure the
Fig. 7 Model for bovine endometrial MSC: mesenchymal to epithelial transition during luteolysis and tropism to inflammation niche for immunomodulation
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immunomodulation necessary in the mother for em-
bryo survival.
eMSCs could act there as primarily suppressive effec-
tors on Th1 cells by suppressing their proliferation, dif-
ferentiation and activation [42, 43]. In accordance, both
analysed lines; eMSC-1A, with a pure mesenchymal pat-
tern and eMSC-4H with a phenotype consistent with
MET, showed the ability to suppress T cell proliferation
in vitro.
Conclusion
In sum, our results show that eMSC isolated and immor-
talized from the uterus shared common MSC features, al-
though eMSCs isolated from the endometrium of the final
phase of the oestrous cycle show a phenotype compatible
with the mesenchymal-epithelium transition. Finally, the
migratory capacity of eMSCs towards an inflammatory
niche and their retention by interferon-τ secreted by the
embryo would ensure the immunomodulatory ambient
necessary for productive pregnancy (Fig. 7).
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